External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home EAHAD 2023
Roche and Genentech at

EAHAD 2023

February 07 - February 10
Manchester, England/ Virtual (Hybrid)
eahadcongress.com
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
01:20 PM
Duration 15mins Exchange Hall
Emicizumab Prophylaxis for the Treatment of Infants with Severe Hemophilia A without Factor VIII Inhibitors: Results from the Interim Analysis of the HAVEN 7 Study
Pipe S, Collins P, Dhalluin C, Kenet G, Schmitt C, Buri M, Jimenez-Yuste V, Peyvandi F, Young G, Oldenburg J, Mancuso M, Kiialainen A, Chang T, Lehle M, Fijnvandraat K
Haematology | Hemophilia A

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.